Post by
Bakunin6 on Jun 14, 2022 3:20pm
Venowave
Worth .50 on venowave alone if not for the chinese supply chain impairment.
The covid mania has skewed the buying toward acuvid but this is hardly a one trick pony.
Comment by
SY3XElon on Jun 14, 2022 3:24pm
Are you talking about the supply chain impairment that Rob said only other companies had but Therma Bright could deliver and then didn't? What a NR that was
Comment by
hk1966 on Jun 14, 2022 3:33pm
I think that is why Rob is doing call with them to better forecast delivery timelines. Yes it sucks but that is the way things are these days. I see it myself in my industry and know that most other firms are in the same boat.
Comment by
spygate on Jun 14, 2022 4:15pm
well I guess we will see how many of those initial units actually sold when they announce it...may not be a one trick pony I agree, but one trick is much biogger than the other...no chance we should be at .50 with Venowave on its own...pipe dream to think that but you can think what you want to think as its your money